Whether she has considered involving compliant private sector laboratories in the production of the African Horse Sickness vaccines on behalf of Onderstepoort Biological Products; if not, why not; if so, with whom has she communicated from the equine and horse racing industry in relation to the availability and distribution of the African Horse Sickness vaccines for the new vaccination season commencing on 1 June 2022?